ISCI Research

Basic Cell Biology, Blood, Bone & Skin, Cancer, Cardiovascular, Diabetes and Nervous System.

Clinical Trials

Clinical Trials

Phase I/II clinical trials testing mesenchymal stem cells (MSC) in cardiology and wound care.


ISCI Leadership

Renowned physician-scientists set a vision for the future of regenerative medicine.

Latest News

Physician-Scientist Receives NIH Grant to Study Stem Cells and Olfactory Loss

The Miller School’s Bradley Goldstein, M.D., Ph.D., assistant professor of otolaryngology, has received a five-year, $1.1 million grant from the National Institutes of Health to study the role of stem cells in olfactory neuron regeneration. Goldstein focuses his clinical and research interests on olfactory disorders.

Read more on the Miller School Web site »

NEJM Publishes Research Finding Medication Slows Devastating Lung Disease

An international team of researchers, including Miller School pulmonologist Marilyn K. Glassberg, M.D., has confirmed the results of earlier trials that pirfenidone, a medication already approved for use in nearly three dozen countries, is effective in slowing the progress of idiopathic pulmonary fibrosis. Their findings were published in the May 20 issue of The New England Journal of Medicine.

Read more on the Miller School Web site »

Study Finds Effective Approach for Delivering Stem Cells to Repair Stroke Damage

A new Miller School research study has identified a safe and effective route for delivering stem cells to the brain, where they can potentially repair stroke-damaged tissue. "Our team found that delivering a low dose of mesenchymal stem cells (MSCs) through the carotid artery at 24 hours after stroke resulted in effective therapy for ischemic stroke in an animal model," said lead author Dileep Yavagal, M.D.

Read more on the Miller School Web site »